SurgePays (SURG) Competitors $2.86 -0.07 (-2.39%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$2.86 0.00 (0.00%) As of 09/25/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock SURG vs. MGRM, INGN, NNOX, CV, STSS, INFU, ELMD, BSGM, KRMD, and AVRShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Monogram Orthopaedics (MGRM), Inogen (INGN), Nano-X Imaging (NNOX), CapsoVision (CV), Sharps Technology (STSS), InfuSystem (INFU), Electromed (ELMD), Biosig Technologies (BSGM), KORU Medical Systems (KRMD), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry. SurgePays vs. Its Competitors Monogram Orthopaedics Inogen Nano-X Imaging CapsoVision Sharps Technology InfuSystem Electromed Biosig Technologies KORU Medical Systems Anteris Technologies Global Monogram Orthopaedics (NASDAQ:MGRM) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment. Which has higher earnings & valuation, MGRM or SURG? Monogram Orthopaedics has higher earnings, but lower revenue than SurgePays. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMonogram Orthopaedics$370K646.79-$16.33M-$0.50-11.78SurgePays$60.88M0.96-$45.73M-$2.49-1.15 Is MGRM or SURG more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to SurgePays' net margin of -133.85%. Monogram Orthopaedics' return on equity of -126.82% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets Monogram OrthopaedicsN/A -126.82% -96.87% SurgePays -133.85%-333.87%-195.36% Do analysts recommend MGRM or SURG? Monogram Orthopaedics currently has a consensus price target of $5.40, indicating a potential downside of 8.32%. SurgePays has a consensus price target of $9.00, indicating a potential upside of 214.69%. Given SurgePays' higher possible upside, analysts clearly believe SurgePays is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in MGRM or SURG? 0.5% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by insiders. Comparatively, 30.5% of SurgePays shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, MGRM or SURG? Monogram Orthopaedics has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Comparatively, SurgePays has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500. Does the media prefer MGRM or SURG? In the previous week, SurgePays had 2 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 3 mentions for SurgePays and 1 mentions for Monogram Orthopaedics. Monogram Orthopaedics' average media sentiment score of 1.92 beat SurgePays' score of 1.29 indicating that Monogram Orthopaedics is being referred to more favorably in the media. Company Overall Sentiment Monogram Orthopaedics Very Positive SurgePays Positive SummaryMonogram Orthopaedics beats SurgePays on 10 of the 16 factors compared between the two stocks. Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SURG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$59.86M$20.09B$32.22B$10.39BDividend YieldN/A3.54%3.17%4.64%P/E Ratio-1.1575.42453.4826.11Price / Sales0.9691.641,736.46124.93Price / CashN/A85.2637.6261.24Price / Book3.768.987.226.30Net Income-$45.73M$355.94M$809.16M$271.03M7 Day Performance-2.72%-1.55%-0.59%-0.14%1 Month Performance14.86%7.25%6.37%5.82%1 Year Performance66.28%82.52%24,153.42%27.63% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays3.3643 of 5 stars$2.86-2.4%$9.00+214.7%+83.3%$59.86M$60.88M-1.1540News CoverageMGRMMonogram Orthopaedics1.5937 of 5 stars$5.84flat$5.40-7.5%+141.4%$237.29M$370K-11.6828Positive NewsINGNInogen4.1395 of 5 stars$8.66flat$11.00+27.0%-16.6%$234.17M$335.70M-8.171,030News CoverageNNOXNano-X Imaging2.7043 of 5 stars$4.02+1.3%$8.50+111.4%-36.4%$229.38M$11.28M-4.47190CVCapsoVisionN/A$4.75+0.2%$5.50+15.8%N/A$221.71MN/A0.0090News CoveragePositive NewsSTSSSharps Technology0.4721 of 5 stars$7.91-3.1%N/AN/A$216.27MN/A-0.013Gap DownINFUInfuSystem4.1546 of 5 stars$10.41+4.1%$13.33+28.1%+70.0%$212.64M$139.89M173.53410High Trading VolumeELMDElectromed3.8818 of 5 stars$24.87+0.4%$36.25+45.8%+18.3%$207.64M$64M33.16160Positive NewsBSGMBiosig Technologies1.6058 of 5 stars$6.35+42.6%$10.00+57.6%+1,773.9%$199.35M$13K0.0050Gap DownHigh Trading VolumeKRMDKORU Medical Systems2.3572 of 5 stars$4.02-3.4%$4.63+15.0%+45.2%$192.34M$33.65M-44.6780AVRAnteris Technologies Global1.5695 of 5 stars$4.90-6.5%$16.50+236.7%N/A$188.97M$2.70M0.00138 Related Companies and Tools Related Companies Monogram Orthopaedics Competitors Inogen Competitors Nano-X Imaging Competitors CapsoVision Competitors Sharps Technology Competitors InfuSystem Competitors Electromed Competitors Biosig Technologies Competitors KORU Medical Systems Competitors Anteris Technologies Global Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SURG) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SURG Stock Alerts